SuperworthStryker Corporation SYK
Medical - Devices, Healthcare
$275.40
−1.01%
- Market cap
- $105.6B
- PE
- 28.5×
- 10y median 41.2×
- Forward PE
- Price to sales
- 4.1×
- EV/EBIT
- 21.2×
- Revenue, 12 months
- $25.8B
- +8% on a year ago
- Net margin
- 14.4%
- Free cash flow yield
- 4.5%
Stryker trades at 28.5× trailing earnings, cheaper than 86% of the last ten years. Revenue was $25.8B over the last twelve months, up 8% on a year earlier with a 14% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.8B | $5.2B | $5.4B | $5.5B | $6.4B+11% | $5.9B+12% | $6B+11% | $6.1B+10% | $7.2B+11% | $6B+3% | $6.6B+9% | |
| Cost of revenue | $2.1B | $1.9B | $2B | $2B | $2.3B+7% | $2.1B+11% | $2.2B+9% | $2.2B+12% | $2.5B+12% | $2.2B+4% | $2.1B−4% |
| Gross profit | $3.7B | $3.3B | $3.4B | $3.5B | $4.2B+13% | $3.7B+12% | $3.8B+12% | $3.9B+10% | $4.6B+11% | $3.8B+2% | $4.5B+17% |
| R&D | $350M | $368M | $363M | $377M | $358M+2% | $405M+10% | $407M+12% | $410M+9% | $401M+12% | $413M+2% | $434M+7% |
| SG&A | $1.9B | $1.8B | $1.8B | $1.9B | $2.1B+11% | $2.3B+25% | $2.1B+14% | $2B+8% | $2.2B+5% | $2.3B−1% | $2.2B+7% |
| $1.3B | $972M | $1.1B | $1.1B | $581M−54% | $837M−14% | $1.1B+6% | $1.1B+5% | $1.8B+211% | $936M+12% | $1.7B+49% | |
| Interest expense | $0 | $0 | $0 | $0 | $0 | $0 | $159M | $157M | $381M | $148M | $0 |
| Pre-tax income | $1.2B | $923M | $998M | $1B | $528M−57% | $764M−17% | $1B+2% | $1B−1% | $1.7B+223% | $850M+11% | $1.6B+54% |
| $83M | $135M | $173M | $209M | −$18M | $110M−19% | $132M−24% | $170M−19% | $856M | $105M−5% | $288M+118% | |
| Net income | $1.1B | $788M | $825M | $834M | $546M−52% | $654M−17% | $884M+7% | $859M+3% | $849M+56% | $745M+14% | $1.3B+44% |
| $2.98 | $2.05 | $2.14 | $2.16 | $1.41−53% | $1.69−18% | $2.29+7% | $2.22+3% | $2.20+56% | $1.93+14% | $3.30+44% | |
| 383.9M | 385.1M | 385.4M | 385.6M | 386.1M+1% | 386.4M+0% | 386.4M+0% | 386.7M+0% | 386.5M+0% | 386.5M+0% | 386M−0% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Medical - Devices within ten times Stryker's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| SYKStryker Corporation | $105.6B | 28.5× | 41.2× | 4.1× | +8% | 14.4% | |
| MDTMedtronic plc | $109.4B | 21.1× | 28.4× | 2.9× | +10% | 13.9% | |
| ABTAbbott Laboratories | $170.8B | 31.8× | 36.2× | 3.7× | +8% | 11.6% | |
| BSXBoston Scientific Corporation | $60.3B | 16.8× | 66.3× | 2.9× | +14% | 17.5% | |
| EWEdwards Lifesciences Corporation | $49.4B | 49.3× | 40.5× | 7.6× | +15% | 15.4% | |
| DXCMDexCom, Inc. | $31.8B | 33.3× | 142× | 6.4× | +16% | 20.1% | |
| GEHCGE HealthCare Technologies Inc. | $29.2B | 18.7× | 19.9× | 1.4× | +7% | 9.3% | |
| Peer median | $54.9B | 26.5× | 38.3× | 3.3× | +12% | 14.7% |
About
- Industry
- Medical - Devices
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .